| Literature DB >> 30823525 |
Laura Bordoni1, Donatella Fedeli2, Cinzia Nasuti3, Filippo Maggi4, Fabrizio Papa5, Martin Wabitsch6, Raffaele De Caterina7, Rosita Gabbianelli8.
Abstract
The oil obtained from the seeds of Nigella sativa L. (N. sativa), also known as black cumin, is frequently used in the Mediterranean area for its anti-inflammatory, anti-oxidant, and anti-cancer activities. The aim of the present study was to evaluate the antioxidant and anti-inflammatory properties of the oil extracted from seeds of a N. sativa cultivar produced in the Marche region of Italy, and to determine if the thymoquinone content, antioxidant properties, and biological activity would decay during storage. Cytotoxicity and anti-inflammatory properties of N. sativa oil were tested in an in vitro model of low-grade inflammation in Simpson⁻Golabi⁻Behmel syndrome human pre-adipocytes. The fresh extracted oil (FEO) contained 33% more thymoquinone than stored extracted oil (SEO), demonstrating that storage affects its overall quality. In addition, the thymoquinone content in the N. sativa oil from the Marche region cultivar was higher compared with other N. sativa oils produced in the Middle East and in other Mediterranean regions. Pro-inflammatory cytokines (e.g., Interleukin (IL)-1alpha, IL-1beta, IL-6) were differently modulated by fresh and stored extracts from N. sativa oils: FEO, containing more thymoquinone reduced IL-6 levels significantly, while SEO inhibited IL-1beta and had a higher antioxidant activity. Total antioxidant activity, reported as µM of Trolox, was 11.273 ± 0.935 and 6.103 ± 0.446 for SEO and FEO (p = 1.255 × 10-7), respectively, while mean values of 9.895 ± 0.817 (SEO) and 4.727 ± 0.324 (FEO) were obtained with the 2,2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH) assay (p = 2.891 × 10-14). In conclusion, the oil capacity to counteract proinflammatory cytokine production does not strictly depend on the thymoquinone content, but also on other antioxidant components of the oil.Entities:
Keywords: Nigella sativa; antioxidant properties; cytokines; human pre-adipocytes; inflammation
Year: 2019 PMID: 30823525 PMCID: PMC6406245 DOI: 10.3390/antiox8020051
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Calibration curve for quantitative determination of thymoquinone using thymol as internal standard (IS).
Thymoquinone concentrations (mg/mL) in stored extracted oil (SEO) and fresh extracted oil (FEO). Intra Day (a) and Inter Day (b) reproducibility.
|
| ||
|
|
|
|
| SEO | 4.767 ± 0.116 | 2.44 |
| FEO | 7.200* ± 0.078 | 1.08 |
|
| ||
|
|
|
|
| SEO | 4.834 ± 0.117 | 2.43 |
| FEO | 7.118* ± 0.083 | 1.18 |
* p < 0.0001 vs sample SEO; RDS: relative standard deviation; SD: standard deviation.
Figure 2(a) Total antioxidant activity (TAA) measured in 2 mL of 2,2’-azinobis-(3-ethylbenz-thiazoline-6-sulfonic acid) (ABTS) solution in the presence of 20 µL of SEO and FEO. The decrease in absorbance at 734 nm of ABTS solution is referred to a standard curve obtained by using known concentrations of Trolox. (b) Antioxidant activity versus DPPH radical was measured in 2 mL of DPPH solution in the presence of 50 µL of SEO and FEO. The decrease in absorbance at 517 nm is referred to a standard curve obtained using known concentrations of Trolox (µM). *** p < 0.001. o1, o3: outliers values.
Luminol-amplified- and lucigenin-amplified chemiluminescence (CL) of SEO and FEO. Antioxidant activity toward H2O2 and O2−. produced in the Luminol-amplified- and lucigenin-amplified-system respectively, was quantified using known amounts of superoxide dismutase (SOD) and catalase (CAT) enzymes. p > 0.05.
| Sample | Luminol-Amplified CL | Lucigenin-Amplified CL |
|---|---|---|
| SEO | 140.68 1 ± 4.66 | 0.0138 2 ± 1.54 × 10−5 |
| FEO | 132.78 1 ± 11.33 1 | 0.0137 2 ± 4.175 × 104 |
Corresponding to µg CAT in sample. Corresponding to µg SOD in sample.
Figure 3Cytotoxicity in pre-adipocyte cells after 24 h of incubation with different concentrations of synthetic thymoquinone concentration (synFEO) dissolved in dimethyl sulfoxide (DMSO). Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and expressed as percentage of the naif cells. 5 µM of SyntFEO resulted in a significant reduction of cell viability. Any cytotoxic effect was observed for 1 µM of SyntFEO respect to DMSO (p > 0.05). ***: p < 0.001.
Figure 4Cytokine level IL-1alpha (a), IL-1beta (b) and IL-6 (c) detected in the cell supernatant after incubation of cells for 24 h in the presence of 1 µM of synFEO dissolved in DMSO. FEO was diluted in DMSO and normalized to 1 µM in thymoquinone content. SEO was added to cell suspension using the same volume employed in FEO sample. * p < 0.05.
Figure 5TAA measured in 2 mL of ABTS solution in the presence of 50 µL of supernatant obtained after incubation of pre-adipocytes for 24 h in the presence of 1 µM of synFEO dissolved in DMSO. FEO was diluted in DMSO and normalized to 1 µM in thymoquinone content. SEO was added to cell suspension using the same volume used for FEO sample. The decrease in absorbance at 734 nm is referred to a standard curve obtained by using known concentrations of Trolox. * p < 0.05 ** p < 0.01.